News & Views | Published:

LIVER CANCER

Gut microbiota as gatekeeper of anti-tumour responses in the liver

Nature Reviews Gastroenterology & Hepatology (2018) | Download Citation

A new report in Science by Ma and colleagues uncovers the interplay of microbiota-controlled bile acid metabolism and immune responses in the context of primary and metastatic liver tumours in mice. Their findings shed light on the gut–liver axis in hepatic malignancies.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1.

    Adolph, T. E. et al. Liver–microbiome axis in health and disease. Trends Immunol. https://doi.org/10.1016/j.it.2018.05.002 (2018).

  2. 2.

    Jia, W., Xie, G. & Jia, W. Bile acid-microbiota crosstalk in gastrointestinal inflammation and carcinogenesis. Nat. Rev. Gastroenterol. Hepatol. 15, 111–128 (2018).

  3. 3.

    Ma, C. et al. Gut microbiome-mediated bile acid metabolism regulates liver cancer via NKT cells. Science 360, eaan5931 (2018).

  4. 4.

    Dapito, D. H. et al. Promotion of hepatocellular carcinoma by the intestinal microbiota and TLR4. Cancer Cell 21, 504–516 (2012).

  5. 5.

    Ponziani, F. R. et al. Hepatocellular carcinoma is associated with gut microbiota profile and inflammation in non-alcoholic fatty liver disease. Hepatology https://doi.org/10.1002/hep.30036 (2018).

  6. 6.

    Bullman, S. et al. Analysis of Fusobacterium persistence and antibiotic response in colorectal cancer. Science 358, 1443–1448 (2017).

  7. 7.

    Sivan, A. et al. Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy. Science 350, 1084–1089 (2015).

  8. 8.

    Routy, B. et al. Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors. Science 359, 91–97 (2018).

  9. 9.

    Gopalakrishnan, V. et al. Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients. Science 359, 97–103 (2018).

  10. 10.

    Shalapour, S. et al. Inflammation-induced IgA+ cells dismantle anti-liver cancer immunity. Nature 551, 340–345 (2017).

Download references

Author information

Affiliations

  1. Department of Internal Medicine I, Gastroenterology, Hepatology, Metabolism & Endocrinology, Medical University Innsbruck, Innsbruck, Austria

    • Timon E. Adolph
    •  & Herbert Tilg

Authors

  1. Search for Timon E. Adolph in:

  2. Search for Herbert Tilg in:

Competing interests

The authors declare no competing interests.

Corresponding author

Correspondence to Herbert Tilg.

About this article

Publication history

Published

DOI

https://doi.org/10.1038/s41575-018-0046-1

Newsletter Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing